Skip to main content
. 2022 Jul 14;9:943778. doi: 10.3389/fcvm.2022.943778

Table 2.

Observed outcomes in each group during the period of follow-up.

Studied population N = 414 SC-group N = 95 STM-group N = 99 ITM-groupN = 220 P-value
Duration of follow-up (days) 341 ± 194 437 ± 190 362 ± 207 276 ± 163 <0.05
Unplanned hospitalization 99 (23.9%) 35 (36.8%) 34 (34.3%) 30 (13.6%) <0.05
All-cause of mortality 46 (11.1%) 16 (16.8%) 20 (20.2%) 10 (4.5%) <0.05
Cardiovascular mortality 30 (7.2%) 8 (8.4%) 15 (15.2%) 7 (3.2%) <0.05